Moat Biotechnology develops oral vaccines designed to accelerate the treatment of infectious diseases within the biopharmaceutical sector
Moat Biotechnology develops oral vaccines designed to accelerate the treatment of infectious diseases within the biopharmaceutical sector. It focuses on the development of intranasal and oral vaccines based on the SC-AdVax platform.